Non‐pharmacological supportive‐care interventions in acute myeloid leukaemia: a review of randomised controlled trials

Abstract

ADL, activity of daily living; AML, acute myeloid leukaemia; BFI, brief fatigue inventory; EORTC, European organisation for research and treatment of cancer; FACT-F, functional assessment of cancer therapy-fatigue; FVC, forced vital capacity; Gln, glutamine dipeptide; HADS, hospital anxiety and depression scale; H(S)CT, haematopoietic (stem) cell transplantation; HRmax, maximum heart rate; HRR, heart rate reserve; IC induction chemotherapy; IMT, inspiratory muscle training; IV, intravenous; IVC, inspiratory vital capacity; LASA, linear analogue self assessment; LOS, length of stay; MISWT, multistage incremental shuttle walk test; OS, overall survival; POMS, profile of mood states; PST, problem-solving training; QLQ-C30, quality of life questionnaire core 30-item; QoL, quality of life; RCT, randomised controlled trial; RPE, rating of perceived exertion; STS, sit-to-standing; TUG, timed up and go; VO 2 , oxygen uptake; 6MWT, 6-minute walk test.